• 855-853-4760
  • customerservice@arevapharma.com

Archive for News

Areva Pharmaceuticals is excited to announce another addition to our growing product portfolio – Temozolomide (oral capsule).

Temozolomide is an alkylating agent indicated for the treatment of adult patients with newly diagnosed glioblastoma multiforme (GBM), a type of primary brain cancer, for which it is given concomitantly with radiotherapy and then as maintenance treatment. Temozolomide is also indicated for the treatment of refractory anaplastic astrocytoma patients who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine; anaplastic astrocytoma is a type of cancer that can occur within the brain and spinal cord. Temozolomide capsules should not be opened or chewed. They should be swallowed whole with a glass of water. Storage: Room temperature; do not refrigerate. Please see our product page for more information. For orders, please contact your wholesaler or order direct via email: customerservice@arevapharma.com

Pamidronate Disodium now available

We are pleased to announce that Pamidronate Disodium for injection is now available. Both the 3mg/10ml and 9mg/10ml sizes are available for immediate shipment in the powder form. Please contact your wholesaler to place an order, or Areva Pharmaceuticals directly at crogers@arevapharma.com.

Ernst & Young announces Areva Pharmaceuticals Founder & CEO Victor Swaminathan as an EY Entrepreneur Of The Year 2015 Award finalist in Ohio Valley

Georgetown, IN, July 27, 2015 – Ernst & Young has announced that Founder & CEO Victor Swaminathan of Areva Pharmaceuticals is a finalist for the EY Entrepreneur Of The Year® 2015 Awards in the Ohio Valley Region. The awards program recognizes entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities. Victor was selected as a finalist by a panel of independent judges.

”I am horned to be an Ernst & Young Entrepreneur Of The Year finalist. This is not just a great mile-stone for me, but for the entire Areva Team. We will continue to build Areva’s presence in Indiana and bring value beyond each vial.

Now in its 29th year, the program has expanded to recognize business leaders in more than 145 cities in more than 60 countries throughout the world.

Regional award winners are eligible for consideration for the EY Entrepreneur Of The Year National program. Award winners in several national categories, as well as the EY Entrepreneur Of The Year National Overall Award winner, will be announced at the annual awards gala in Palm Springs, California, on November 14, 2015. The awards are the culminating event of the EY Strategic Growth Forum®, the nation’s most prestigious gathering of high-growth, market-leading companies.


Founded and produced by EY, the Entrepreneur Of The Year Awards are nationally sponsored by the Ewing Marion Kauffman Foundation and SAP America.

VAWD Approval

On December 19, 2014, Areva Pharmaceuticals was granted VAWD accreditation by NABP (National Association of Boards of Pharmacy). VAWD, or Verified Accredited Wholesale Distributor, is a special accreditation established in 2004 and whose purpose is to protect patients by keeping counterfeit or contaminated prescription drugs from entering the US market. Prescription drugs sometime follow a complex path from manufacturer to patient, and NABP along with the VAWD accreditation for wholesale distributors ensure that facilities which achieve VAWD accreditation have shown compliance with state and federal laws with regards to licensing, security and background screening, detailed operations standards, as well as other criteria set forth by NABP. VAWD facilities, in addition, have undergone a site survey to ensure all practices are being carried forth according to rigorous standards. Facilities are regular reviewed, both on site and through policies and regulations to ensure that compliance continues.

”I am horned to be an In 2003 NABP created a task force to focus on protection from counterfeit and contaminated drugs, making it difficult for illegitimate businesses to flow these drugs through the marketplace. Today, twenty one states recognize VAWD and more states are implementing changes in their own state laws and licensing practices to reflect the higher standard that VAWD sets forth.

Amerinet Award

After submission of bids in April 2014, Areva Pharmaceuticals was pleased to announce it was awarded contracts by Amerinet for Irinotecan and Pamidronate in July 2014.

”I am horned to be an Amerinet GPO (Group Purchasing Organization) is an organization that strives to lower healthcare costs and ensure quality care by working with acute and non-acute healthcare providers. They provide ongoing assistance for hospitals, surgical centers, long-term care centers, clinics, and doctor’s offices to deliver support on safety issues, cost lowering strategies, and operational efficiencies.

Next Page